VivoSim Labs, Inc. Common Stock is a biological products, (no disgnostic substances) company trading on NASDAQ, led by CEO Keith E. Murphy, with a market cap of $4.4M.
Common questions about VivoSim Labs, Inc. Common Stock
VivoSim Labs, Inc. Common Stock is scheduled to report earnings for Q4 2026 on June 4, 2026.
VivoSim Labs, Inc. Common Stock has approximately 14 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.